Exploiting DNA Replication Stress for Cancer Treatment

• Published in: Cancer research (Chicago, Ill.) Vol. 79; no. 8; pp. 1730 - 1739
• Main Authors: Ubhi, Tajinder, Brown, Grant W
• Format: Journal Article
• Language: English
• Published: United States 15.04.2019
• Subjects: Animals; Antineoplastic Agents - therapeutic use; DNA Damage - drug effects; DNA Replication - drug effects; Genomic Instability; Humans; Neoplasms - drug therapy; Neoplasms - genetics
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.can-18-3631

Complete and accurate DNA replication is fundamental to cellular proliferation and genome stability. Obstacles that delay, prevent, or terminate DNA replication cause the phenomena termed DNA replication stress. Cancer cells exhibit chronic replication stress due to the loss of proteins that protect or repair stressed replication forks and due to the continuous proliferative signaling, providing an exploitable therapeutic vulnerability in tumors. Here, we outline current and pending therapeutic approaches leveraging tumor-specific replication stress as a target, in addition to the challenges associated with such therapies. We discuss how replication stress modulates the cell-intrinsic innate immune response and highlight the integration of replication stress with immunotherapies. Together, exploiting replication stress for cancer treatment seems to be a promising strategy as it provides a selective means of eliminating tumors, and with continuous advances in our knowledge of the replication stress response and lessons learned from current therapies in use, we are moving toward honing the potential of targeting replication stress in the clinic.